BMAL2 and cutaneous melanoma: In addition, ARNTL2 was expressed at low levels in only three cancer types, including adrenocortical carcinoma (ACC), prostate adenocarcinoma (PRAD), and skin cutaneous melanoma (SKCM) (Figure 1A).